Lawsuit against two Clearbridge units dismissed over jurisdiction issue

A LAWSUIT filed by a joint venture partner of a ClearBridge Health unit has been dismissed by an Indonesian court due to a jurisdiction issue, the Catalist-listed company announced in a Tuesday bourse filing.

In mid-2020, Clearbridge disclosed that its unit Clearbridge Medical Asia and indirect subsidiary Tirta Medika Jaya (TMJ) were being sued by Tirta Medika Nusantara (TMN), a shareholder of TMJ. TMN was seeking damages of 1.06 trillion rupiah (S$102 million) relating to a notarial deed.

At a hearing on Monday, the North Jakarta District Court dismissed the lawsuit on the basis that pursuant to the shareholders' agreement of TMJ, the court did not have jurisdiction to hear the suit.

The North Jakarta Court also directed TMN to pay the court administrative fees of about S$153.35. TMN may submit an appeal within 14 days after June 7.

Shares of Clearbridge closed at S$0.15 on Tuesday, down 0.66 per cent.